ACORDA THERAPEUTICS INC (ACOR)

Overview Price 25.82 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 2 - BUY Open Price $0.00 Previous Close $25.82 Daily Range $0.00 - $0.00 52-Week Range $18.36 - $33.48 Volume 0 Acorda Therapeutics is commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Acorda currently markets Zanaflex Capsules for the management of spasticity. The Company's lead product candidate, Fampridine-SR, for the improvement of walking ability in persons with multiple sclerosis. It develops therapies that restore neurological function to people with spinal cord injury, multiple sclerosis and related conditions of the nervous system. Other Resources for ACOR Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Ampyra Drives Acorda Revenues November 9, 2011 Zacks Blog: Company News for October 6, 2011 October 6, 2011 Zacks Blog: Unfavorable Ruling for Acorda September 12, 2011 Zacks Blog: Acorda Gains, But Misses Estimates August 4, 2011 Zacks Blog: Company News for August 2, 2011 August 2, 2011 Acorda Therapeutics is commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Acorda currently markets Zanaflex Capsules for the management of spasticity. The Company's lead product candidate, Fampridine-SR, for the improvement of walking ability in persons with multiple sclerosis. It develops therapies that restore neurological function to people with spinal cord injury, multiple sclerosis and related conditions of the nervous system.   Brokerage Analyst Recommendations 8 Brokerage Firms Covering ACOR   Strong Buy 2 Buy 1 Hold 4 Sell 0 Strong Sell 1 Average Broker Recommendation (ABR): 2.63   ACOR Ratings: BUY  SELL  HOLD ACOR Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 32 Buy 11 Sell   Top Buy Analysis BUY: ACOR Company: ACORDA THERAPEUTICS INC. Points: -42.03 Start Price: $32.56 Start Date: 06/21/2010 11:14 AM bullbear P&P Score: 98.25 Recs: rating increase Comments: 0 | Comment More Recent Analysis Top Sell Analysis SELL: ACOR Company: ACORDA THERAPEUTICS INC. Points: 26.65 Start Price: $31.80 Start Date: 07/07/2008 10:23 AM AtomicHawg P&P Score: 58.47 Recs: Comments: 0 | Comment More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
ThisColoradoKid	99.69	03/25/10	3-25-10: Profit - Taking	0
zantriocom	0.00	01/25/10	Zantrio.com Free Daily Stock Picks 1-25-2010	0
Zacks_Analysts	0.00	11/09/11	Ampyra Drives Acorda Revenues - Analyst Blog	0
Zacks_Analysts	0.00	08/04/11	Acorda Gains, But Misses Estimates - Analyst Blog	0
Zacks_Analysts	0.00	07/25/11	Conditional EU Approval for Fampyra - Analyst Blog	0
Zacks_Analysts	0.00	07/06/11	Acorda Inks Deal with Medtronic - Analyst Blog	0
Zacks_Analysts	0.00	06/13/11	Mixed Data on Acorda's Ampyra - Analyst Blog	0
Zacks_Analysts	0.00	05/23/11	CHMP Backs Biogen's Fampyra - Analyst Blog	0
Zacks_Analysts	0.00	05/18/11	Australian Nod for Biogen's Fampyra - Analyst Blog	0
Zacks_Analysts	0.00	05/09/11	ALKS to Buy Elan Unit for $960M - Analyst Blog	0

Pages: [ 1 ]  2   3   4  >>

Commentary

BUY: ACORDA THERAPEUTICS INC. (ACOR) Start Price: $32.80 Points: -23.55 Created: 05/25/2011 New uptrend Comments: 0 | Comment wallstreeter Recs:

BUY: ACORDA THERAPEUTICS INC. (ACOR) Start Price: $32.56 Points: -42.03 Created: 06/21/2010 rating increase Comments: 0 | Comment bullbear Recs:

BUY: ACORDA THERAPEUTICS INC. (ACOR) Start Price: $19.69 Points: -29.15 Created: 04/03/2009 Following advice from mage Comments: 0 | Comment clayton1960 Recs:

BUY: ACORDA THERAPEUTICS INC. (ACOR) Start Price: $32.81 Points: -26.53 Created: 06/23/2011 Comments: 0 | Comment dmonnie Recs:

BUY: ACORDA THERAPEUTICS INC. (ACOR) Start Price: $36.29 Points: -45.72 Created: 05/11/2010 Comments: 0 | Comment harish63 Recs:

BUY: ACORDA THERAPEUTICS INC. (ACOR) Start Price: $23.74 Points: -41.90 Created: 07/02/2009 Comments: 0 | Comment LeveneOMurray Recs:

BUY: ACORDA THERAPEUTICS INC. (ACOR) Start Price: $18.51 Points: +4.94 Created: 10/13/2008 Comments: 0 | Comment EyePod Recs:

SELL: ACORDA THERAPEUTICS INC. (ACOR) Start Price: $32.55 Points: +30.63 Created: 07/14/2008 Comments: 0 | Comment UncleSmitty Recs:

SELL: ACORDA THERAPEUTICS INC. (ACOR) Start Price: $32.55 Points: +30.63 Created: 07/13/2008 Comments: 0 | Comment HeyMikey Recs:

SELL: ACORDA THERAPEUTICS INC. (ACOR) Start Price: $31.80 Points: +26.65 Created: 07/07/2008 Comments: 0 | Comment AtomicHawg Recs:

Pages: [ 1 ]  2   3   4   5  >>

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
dmonnie	0.21	BUY	One to Three Months	06/23/2011	$32.81	$25.85 (-2.31%)	-21.21%	+5.31%	-26.53
wallstreeter	0.23	BUY	Six Months to a Year	05/25/2011	$32.80	$25.85 (-2.31%)	-21.19%	+2.36%	-23.55	view close
bullbear	98.25	BUY	Week to a Month	06/21/2010	$32.56	$25.85 (-2.31%)	-20.61%	+21.42%	-42.03	view close
harish63	0.54	BUY	Three Plus Years	05/11/2010	$36.29	$25.85 (-2.31%)	-28.77%	+16.95%	-45.72
LeveneOMurray	0.45	BUY	Week or Less	07/02/2009	$23.74	$25.85 (-2.31%)	+8.89%	+50.79%	-41.90
clayton1960	21.51	BUY	Week or Less	04/03/2009	$19.69	$25.85 (-2.31%)	+31.28%	+60.44%	-29.15	view close
EyePod	72.86	BUY	Week to a Month	10/13/2008	$18.51	$25.85 (-2.31%)	+39.65%	+34.72%	+4.94
UncleSmitty	53.55	SELL	Six Months to a Year	07/14/2008	$32.55	$25.85 (-2.31%)	-20.58%	+10.04%	+30.63
HeyMikey	57.55	SELL	Three to Six Months	07/13/2008	$32.55	$25.85 (-2.31%)	-20.58%	+10.04%	+30.63
AtomicHawg	58.47	SELL	Six Months to a Year	07/07/2008	$31.80	$25.85 (-2.31%)	-18.71%	+7.93%	+26.65

Pages: [ 1 ]  2   3   4   5  >>